Altec

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Altec sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials 1 currently recruiting 3 completed upper quartile by trial count

Altec: 4 sponsored US clinical trials, 1 recruiting.

Altec sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Communication Disorders, with 1 trials.

Upper-quartile sponsor footprint

Altec sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

4 total, page 1 of 1

RECRUITING NA

Adaptive and Individualized AAC Phase II

NCT06337188
COMPLETED NA

MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments

NCT04762043
COMPLETED NA

Precision Gait Retraining for Children With Cerebral Palsy

NCT04717323
COMPLETED NA

Adaptive and Individualized AAC

NCT04247828

Therapeutic Areas

Communication Disorders 1

What is open in the Altec pipeline

1 recruiting of 4 indexed (25% open); 3 completed (75%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Communication Disorders (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Altec: open-pipeline peers nationwide

Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

Altec sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3456789 0%20%40%60%80% Total trials Recruiting share Altec4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action LabAB ScienceAbbott Point of CareAccutar BiotechnologyAdrienne G. Waks
Altec sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Altec sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Altec page

4 registered trials is a research-attention snapshot, not an endorsement of Altec or any single study.

  • 1 of Altec's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Communication Disorders is the condition Altec studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Communication Disorders trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Altec pipeline card: 4 registered trials from official public datasets.Report a data error.